US FDA Accepts New Drug Application Filing for Isavuconazole
Drug developer Astellas has applied for approval to bring its new antifungal medication to clinics in the United States (this antifungal drug approval application has already been accepted in Europe), A decision in the US is scheduled for March 8th 2015.
Quoting:
The US Food and Drug Administration (US FDA) has accepted for filing the New Drug Application (NDA) for Astellas' isavuconazole
0 Response to "US FDA Accepts New Drug Application Filing for Isavuconazole "
Post a Comment